Nevertheless, a recent study found human PHGDH to be able to catalyze the NADH-dependent reduction of α-KG to D-2-hydroxyglutarate, an oncometabolite associated with brain cancer and acute myeloid leukemia [11]. The gene discussed is PHGDH; the disease is brain cancer.